Coronado Biosciences, Inc. (CNDO):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Coronado Biosciences, Inc. (CNDO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135290FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Coronado Biosciences, Inc., (Coronado Biosciences) is a biopharmaceutical company. The company develops novel immunotherapy biologic agents for autoimmune diseases and cancer. Its products pipeline includes TSO and CNDO-109. Coronado Biosciences’ TSO product includes autoimmune therapeutics market, hygiene hypothesis, immune system and autoimmune disease, inflammatory bowel disease and multiple sclerosis. The company’s CNDO-109 products include oncology therapeutics market and AML. Its pharmaceutical product candidates are mainly targeted for clinical development for inflammatory bowel disease, multiple sclerosis and acute myeloid leukemia. The company collaborates with OvaMed and Dr. Falk Pharma GmbH for the development of TSO for Crohn’s disease. Coronado Biosciences is headquartered in Burlington, Massachusetts, the US.

Coronado Biosciences, Inc. Key Recent Developments

Dec 20, 2013: Coronado Biosciences Announces Management Changes
Nov 06, 2013: Coronado Biosciences Announces Personnel Realignment, Including Appointment of Kevin Horgan, M.D., as Chief Medical Officer
Nov 01, 2013: Coronado Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2013
Sep 03, 2013: Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences
Aug 27, 2013: Coronado Biosciences to Participate in Citi’s 8th Annual Biotech Conference

This comprehensive SWOT profile of Coronado Biosciences, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Coronado Biosciences, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Coronado Biosciences, Inc. – Key Information
Coronado Biosciences, Inc. – Overview
Coronado Biosciences, Inc. – Key Employees
Coronado Biosciences, Inc. – Key Employee Biographies
Coronado Biosciences, Inc. – Key Operational Heads
Coronado Biosciences, Inc. – Major Products and Services
Coronado Biosciences, Inc. – History
Coronado Biosciences, Inc. – Company Statement
Coronado Biosciences, Inc. – Locations And Subsidiaries
Coronado Biosciences, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Coronado Biosciences, Inc. – Business Description
Coronado Biosciences, Inc. – Corporate Strategy
Coronado Biosciences, Inc. – SWOT Analysis
SWOT Analysis – Overview
Coronado Biosciences, Inc. – Strengths
Coronado Biosciences, Inc. – Weaknesses
Coronado Biosciences, Inc. – Opportunities
Coronado Biosciences, Inc. – Threats
Coronado Biosciences, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Coronado Biosciences, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Coronado Biosciences, Inc., Key Information
Coronado Biosciences, Inc., Key Ratios
Coronado Biosciences, Inc., Share Data
Coronado Biosciences, Inc., Major Products and Services
Coronado Biosciences, Inc., History
Coronado Biosciences, Inc., Key Employees
Coronado Biosciences, Inc., Key Employee Biographies
Coronado Biosciences, Inc., Key Operational Heads
Coronado Biosciences, Inc., Other Locations
Coronado Biosciences, Inc., Subsidiaries
Coronado Biosciences, Inc., Key Manufacturing facilities
Coronado Biosciences, Inc., Key Competitors
Coronado Biosciences, Inc., SWOT Analysis
Coronado Biosciences, Inc., Ratios based on current share price
Coronado Biosciences, Inc., Annual Ratios
Coronado Biosciences, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Coronado Biosciences, Inc., Performance Chart
Coronado Biosciences, Inc., Ratio Charts

★海外企業調査レポート[Coronado Biosciences, Inc. (CNDO):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Applied Maths NV:企業のM&A・提携動向(医療機器分野)
    Summary Applied Maths NV (Applied Maths), a subsidiary of bioMerieux S.A. is a pharmaceutical company that designs, develops and markets various software products for bioscience industry. The company’s software products include bionumerics, gelcompar, genemaths xt, kodon and bionumerics 2D. Its bion …
  • The Kroger Co.:企業概要・SWOT・財務分析
    Summary Canadean's "The Kroger Co. : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company hi …
  • Fertilizantes Heringer S.A. (FHER3):企業概要、財務及び戦略的SWOT分析
    Summary Fertilizantes Heringer S.A. (Heringer) is a chemical company. The company produces, markets and distributes fertilizers. Its products include potassium chloride, ammonia sulphate, reactive phosphate, and NPK formulas. Heringer offers services such as soil analysis programs, pre-sales and pos …
  • Yonex Co. Ltd.の企業概要及び財務/SWOT分析
    Yonex Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Yonex Co. Ltd. annual and quarterly forecasts made by stock market experts. The report also enables direct comp …
  • LEIFHEIT AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LEIFHEIT AG Mergers and Acquisi …
  • Peat Resources Limited (PET):企業の財務及び戦略的SWOT分析
    Summary Peat Resources Limited (Peat Resources) is an energy company that develops and produces peat fuels. The Company provides products such as peat, a biomass that is used for electricity generations. Its product peat is a source material for value-added biocarbon products such as activated carbo …
  • GRI Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for live …
  • iControl Networks, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' iControl Networks, Inc. Mergers …
  • The Housing Bank for Trade and Finance:企業の戦略・SWOT・財務分析
    SummaryThe Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • Craftmade International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Craftmade International, Inc. M …
  • KTM AG (formerly KTM Power Sports AG):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' KTM AG (formerly KTM Power Spor …
  • Chronix Biomedical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Chronix Biomedical, Inc. (Chronix Biomedical) is a molecular diagnostic company. The company develops blood tests for monitoring minimal residual disease in cancer patients. It develops test kits that are used for the detection and monitoring of chronic diseases in human beings and animals. …
  • Datang International Power Generation Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Datang International Power Gene …
  • The Home Depot, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Home Depot, Inc. Mergers an …
  • Doosan Fuel Cell America, Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Doosan Fuel Cell America, Inc (Doosan Fuel Cell), formerly known as ClearEdge Power, Inc. a subsidiary of Doosan Corporation is an energy solution provider which manufactures and markets clean energy solutions. The company provides installation, remote monitoring and control, equipment servi …
  • Portola Pharmaceuticals, Inc. (PTLA):企業の財務及び戦略的SWOT分析
    Summary Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company. It undertakes the discovery and development of therapeutics for the treatment of cardiovascular, inflammation, and oncology indications. The company’s product portfolio includes Betrixaban, Andexanet Alfa (PRT4445), PRT2 …
  • EV Energy Partners, L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EV Energy Partners, L.P. Merger …
  • Harris Corporation (HRS):企業のM&A・提携動向(医療機器分野)
    Summary Harris Corporation (Harris) is a communications and information technology company that offers communications products, services and systems, and network solutions. The company offers tactical and land mobile radio systems, IT services, clinically integrated solutions, managed services, gove …
  • Wolfgang Puck Worldwide, Inc.:企業の戦略・SWOT・財務分析
    SummaryWolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Chesapeake Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Chesapeake Limited Mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆